The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients

Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, et al.

Arthritis Rheumatol · 2015

Grade Bretrospective studyn=57Unverified
DOI ↗PubMed ↗

Key Findings

  • ●Largest cohort study: 57 patients with HUV
  • ●Angioedema in 51%, musculoskeletal 82%, ocular 56%, pulmonary 19%, renal 14%
  • ●Evaluated treatment efficacy via time-to-treatment failure
  • ●Hydroxychloroquine, colchicine, and corticosteroids as first-line therapy

Referenced in (1 disease)

Hypocomplementemic Urticarial Vasculitis Syndrome

Validation history

Full log →

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.

ID: pmid-25385679DOI: 10.1002/art.38956PMID: 25385679